Tuesday, 02 January 2024 12:17 GMT

Cardiac Monitoring Devices Market Poised For Growth Through 2034 As AI, Wearables And Remote Patient Monitoring Unlock New Opportunities


(MENAFN- GlobeNewsWire - Nasdaq) Rising heart disease and home-based care are driving demand for wearable, AI-enabled cardiac devices, creating opportunities in remote monitoring and Asia-Pacific.

Dublin, Sept. 16, 2026 (GLOBE NEWSWIRE) -- "Cardiac Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034" has been added to ResearchAndMarkets.com's offering.

Global Cardiac Monitoring Devices Market to Reach USD 34.94 Billion by 2034 as Remote Patient Monitoring Adoption Accelerates

The global cardiac monitoring devices market is projected to increase from USD 22.31 billion in 2025 to USD 34.94 billion by 2034, expanding at a compound annual growth rate (CAGR) of 5.17% from 2026 to 2034. Market growth is being supported by the rising prevalence of cardiovascular diseases, expanding remote patient monitoring programs, increased adoption of home-based care, and continued innovation in wearable and connected cardiac technologies.

Cardiac Monitoring Devices Market Growth Drivers

The increasing incidence of heart failure, coronary artery disease, arrhythmias, atrial fibrillation, and hypertension is creating sustained demand for cardiac monitoring devices. Aging populations and the growing prevalence of obesity, diabetes, sedentary lifestyles, and other cardiovascular risk factors are increasing the need for early diagnosis, continuous surveillance, and long-term disease management.

According to the Institute for Health Metrics and Evaluation, ischemic heart disease affected an estimated 240 million people worldwide in 2023. The World Health Organization also reported that approximately 2.5 billion adults were overweight, including 890 million living with obesity. These trends are increasing demand for ECG systems, Holter monitors, implantable loop recorders, wearable ECG patches, event recorders, and mobile cardiac telemetry systems.

Remote patient monitoring is another major contributor to cardiac monitoring devices market growth. Healthcare providers are increasingly using wearable and wireless solutions to transmit cardiac data to clinicians, support timely intervention, reduce hospital visits, and lower readmission rates. The expansion of telehealth infrastructure and decentralized care is strengthening demand for cloud-connected platforms, smart wearables, patch-based monitors, and long-term ambulatory monitoring systems.

Technological advances are further improving product accuracy, portability, connectivity, battery performance, and patient comfort. Artificial intelligence is increasingly being integrated into cardiac monitoring platforms to analyze ECG data, identify clinically significant events, prioritize alerts, and support earlier detection of arrhythmias and other cardiac abnormalities. These capabilities are improving clinical workflows while supporting personalized and preventive cardiac care.

Product and End-User Segment Analysis

The cardiac monitoring devices market is segmented by product type into ECG devices, implantable loop recorders, event recorders, echocardiography systems, mobile cardiac telemetry, and other solutions. The ECG devices category includes Holter monitors, resting ECG systems, and stress ECG systems. Within this segment, Holter monitors are estimated to account for the largest market share in 2025, supported by their established role in ambulatory rhythm monitoring and arrhythmia detection.

By end user, the market includes hospitals, ambulatory surgical centers, homecare settings, and other healthcare environments. Homecare settings are gaining strategic importance as healthcare systems increase their use of remote monitoring, virtual consultations, and long-term outpatient cardiac management.

Regional Cardiac Monitoring Devices Market Outlook

North America is expected to represent approximately 41% of the global cardiac monitoring devices market in 2025, maintaining the leading regional position. Growth is supported by the high burden of cardiovascular disease, advanced healthcare infrastructure, favorable reimbursement conditions, strong telehealth adoption, and the early introduction of AI-enabled wearables and remote monitoring systems.

The Centers for Disease Control and Prevention estimated that approximately 12.1 million people in the United States could have atrial fibrillation by 2050. Greater awareness of cardiovascular health, preventive screening initiatives, and continued U.S. Food and Drug Administration clearances are expected to reinforce regional demand.

Europe is also contributing significantly to market expansion. The region benefits from established healthcare systems, supportive digital health initiatives, growing use of remote patient monitoring, and increased investment in wearable ECG and AI-enabled analysis technologies. Demand for Holter monitors, telemetry systems, implantable loop recorders, and ambulatory ECG devices remains strong across major European markets.

Asia-Pacific is expected to offer substantial growth opportunities as cardiovascular disease prevalence rises across China, India, Japan, and other regional markets. Healthcare infrastructure investment, aging populations, urbanization, and the expansion of digital health services are supporting adoption. Governments and healthcare providers are also developing remote monitoring programs to improve access to cardiac care in rural and underserved communities.

Recent Cardiac Monitoring Technology Developments

  • In July 2025, the FDA cleared CardioTag, a wearable device capable of capturing electrocardiogram, photoplethysmogram, and seismocardiogram signals.
  • In May 2025, iRhythm Technologies launched its Zio long-term continuous ECG monitoring system in Japan, providing up to 14 days of monitoring with deep-learning algorithms approved by Japan's Pharmaceuticals and Medical Devices Agency.
  • In March 2025, Sibel Health received its seventh FDA 510(k) clearance for the ANNE One wireless monitoring platform, which continuously captures ECG, heart rate, respiratory rate, and additional physiological parameters.
  • In March 2025, Peerbridge Health introduced Cor MDx, a three-lead, two-channel wearable designed to detect up to 31 arrhythmias and support Holter monitoring, mobile cardiac telemetry, and hemodynamic assessment.
  • In November 2024, Fourth Frontier received FDA 510(k) clearance for Frontier X Plus, a chest-worn continuous ECG monitor that transmits data to remote monitoring dashboards.
  • In June 2024, Endotronix received FDA Premarket Approval for the Cordella PA Sensor System for remote management of patients with NYHA Class III heart failure.
  • In January 2024, iRhythm Technologies received CE Mark certification under the European Union Medical Device Regulation for its next-generation Zio ECG monitoring system and ZEUS AI-powered analysis platform.

Competitive Landscape

Competition within the cardiac monitoring devices market is increasingly focused on artificial intelligence, wireless connectivity, cloud integration, longer monitoring duration, miniaturization, and improved user experience. Established medical device manufacturers are expanding their portfolios through research and development, regulatory approvals, product launches, partnerships, mergers, and acquisitions. Emerging digital health companies are also entering the market with wearable and remote monitoring technologies designed for both clinical and homecare applications.

Leading companies include Koninklijke Philips N.V., Boston Scientific Corporation, Medtronic, Neurosoft, ACS Diagnostics, Abbott, Biotronik, GE HealthCare, AliveCor Inc., ZOLL Medical Corporation, Bexen Cardio, iRhythm Technologies, Inc., Osypka Medical, Nihon Kohden Corporation, BPL Medical Technologies, Schiller AG, Mindray, Dragerwerk AG & Co. KGaA, Lepu Medical Technology, and Fukuda Denshi Co., Ltd.

Market Challenges and Tariff Considerations

Despite the favorable outlook, market expansion may be affected by data privacy concerns, cybersecurity threats, high device costs, battery limitations, connectivity problems, maintenance requirements, and inconsistent access to trained professionals. Device accuracy and the management of large volumes of cardiac data also remain important considerations for healthcare providers.

U.S. tariffs on imported semiconductors, sensors, electronic components, and medical device parts may increase manufacturing and procurement costs. Manufacturers are responding by diversifying suppliers, negotiating long-term agreements, strengthening domestic production, and investing in more resilient supply chains. Larger companies may be better positioned to absorb cost increases, while smaller manufacturers could experience greater margin pressure.

Cardiac Monitoring Devices Market Report Scope

The report analyzes the cardiac monitoring devices market by product type, end user, and geography. Geographic coverage includes North America, Europe, Asia-Pacific, South America, the Middle East, and Africa, with detailed analysis of major national markets. It also evaluates market drivers, restraints, regulatory developments, competitive strategies, product innovation, artificial intelligence applications, tariff exposure, and emerging investment opportunities.

Overall, the increasing global burden of cardiovascular disease, rising demand for remote patient monitoring, expansion of home-based care, and continued introduction of AI-enabled and wearable cardiac monitoring devices are expected to support sustained market growth through 2034.

Key Topics Covered:
1. Cardiac Monitoring Devices Market Report Introduction
1.1 Scope of the Study
1.2 Market Segmentation
1.3 Market Assumption
2. Cardiac Monitoring Devices Market Executive Summary
2.1 Market at Glance
3. Cardiac Monitoring Devices Market Key Factors Analysis
3.1 Cardiac Monitoring Devices Market Drivers
3.1.1 The increasing prevalence of cardiovascular diseases and related risk factors
3.1.2 Increasing demand for remote patient monitoring
3.1.3 Rising technological advancements and enhanced product development initiatives by key market players
3.2 Cardiac Monitoring Devices Market Restraints and Challenges
3.2.1 Data privacy and security
3.2.2 Limitations associated with the devices, such as motion artifacts, battery storage, and others
3.3 Cardiac Monitoring Devices Market Opportunity
3.3.1 Integration of AI and machine learning for the interpretation of cardiac data
4. Impact Analysis
4.1 AI-Powered Innovations and Applications
4.2 U.S. Tariff Impact Analysis
5. Regulatory Analysis
5.1 The United States
5.2 Europe
5.3 Japan
5.4 China
6. Cardiac Monitoring Devices Market Porter's Five Forces Analysis
6.1 Bargaining Power of Suppliers
6.2 Bargaining Power of Consumers
6.3 Threat of New Entrants
6.4 Threat of Substitutes
6.5 Competitive Rivalry
7. Cardiac Monitoring Devices Market Assessment
7.1 By Product Type
7.1.1 ECG Devices
7.1.1.1 Holter Monitors
7.1.1.2 Resting ECG
7.1.1.3 Stress ECG
7.1.2 Implantable Loop Recorders
7.1.3 Event Recorders
7.1.4 Echocardiogram
7.1.5 Mobile Cardiac Telemetry
7.1.6 Others
7.2 By End-Users
7.2.1 Hospitals
7.2.2 Ambulatory Surgical Centers
7.2.3 Homecare Settings
7.2.4 Others
7.3 By Geography
7.3.1 North America
7.3.1.1 United States Cardiac Monitoring Devices Market Size in USD million (2023-2034)
7.3.1.2 Canada Cardiac Monitoring Devices Market Size in USD million (2023-2034)
7.3.1.3 Mexico Cardiac Monitoring Devices Market Size in USD million (2023-2034)
7.3.2 Europe
7.3.2.1 France Cardiac Monitoring Devices Market Size in USD million (2023-2034)
7.3.2.2 Germany Cardiac Monitoring Devices Market Size in USD million (2023-2034)
7.3.2.3 United Kingdom Cardiac Monitoring Devices Market Size in USD million (2023-2034)
7.3.2.4 Italy Cardiac Monitoring Devices Market Size in USD million (2023-2034)
7.3.2.5 Spain Cardiac Monitoring Devices Market Size in USD million (2023-2034)
7.3.2.6 Rest of Europe Cardiac Monitoring Devices Market Size in USD million (2023-2034)
7.3.3 Asia-Pacific
7.3.3.1 China Cardiac Monitoring Devices Market Size in USD million (2023-2034)
7.3.3.2 Japan Cardiac Monitoring Devices Market Size in USD million (2023-2034)
7.3.3.3 India Cardiac Monitoring Devices Market Size in USD million (2023-2034)
7.3.3.4 Australia Cardiac Monitoring Devices Market Size in USD million (2023-2034)
7.3.3.5 South Korea Cardiac Monitoring Devices Market Size in USD million (2023-2034)
7.3.3.6 Rest of Asia-Pacific Cardiac Monitoring Devices Market Size in USD million (2023-2034)
7.3.4 Rest of the World (RoW)
7.3.4.1 Middle East Cardiac Monitoring Devices Market Size in USD million (2023-2034)
7.3.4.2 Africa Cardiac Monitoring Devices Market Size in USD million (2023-2034)
7.3.4.3 South America Cardiac Monitoring Devices Market Size In USD Million (2023-2034)
8. Competitive Landscape
9. Startup Funding & Investment Trends
10. Cardiac Monitoring Devices Market Company and Product Profiles
10.1 Medtronic
10.1.1 Company Overview
10.1.2 Company Snapshot
10.1.3 Financial Overview
10.1.4 Product Listing
10.1.5 Entropy
10.2 Boston Scientific Corporation
10.2.1 Company Overview
10.2.2 Company Snapshot
10.2.3 Financial Overview
10.2.4 Product Listing
10.2.5 Entropy
10.3 Neurosoft
10.3.1 Company Overview
10.3.2 Company Snapshot
10.3.3 Financial Overview
10.3.4 Product Listing
10.3.5 Entropy
10.4 ACS Diagnostics
10.4.1 Company Overview
10.4.2 Company Snapshot
10.4.3 Financial Overview
10.4.4 Product Listing
10.4.5 Entropy
10.5 Biotronik
10.5.1 Company Overview
10.5.2 Company Snapshot
10.5.3 Financial Overview
10.5.4 Product Listing
10.5.5 Entropy
10.6 Abbott
10.6.1 Company Overview
10.6.2 Company Snapshot
10.6.3 Financial Overview
10.6.4 Product Listing
10.6.5 Entropy
10.7 Koninklijke Philips NV
10.7.1 Company Overview
10.7.2 Company Snapshot
10.7.3 Financial Overview
10.7.4 Product Listing
10.7.5 Entropy
10.8 GE Healthcare
10.8.1 Company Overview
10.8.2 Company Snapshot
10.8.3 Financial Overview
10.8.4 Product Listing
10.8.5 Entropy
10.9 AliveCor Inc.
10.9.1 Company Overview
10.9.2 Company Snapshot
10.9.3 Financial Overview
10.9.4 Product Listing
10.9.5 Entropy
10.10 ZOLL Medical Corporation
10.10.1 Company Overview
10.10.2 Company Snapshot
10.10.3 Financial Overview
10.10.4 Product Listing
10.10.5 Entropy
10.11 Bexen Cardio
10.11.1 Company Overview
10.11.2 Company Snapshot
10.11.3 Financial Overview
10.11.4 Product Listing
10.11.5 Entropy
10.12 iRhythm Technologies Inc.
10.12.1 Company Overview
10.12.2 Company Snapshot
10.12.3 Financial Overview
10.12.4 Product Listing
10.12.5 Entropy
10.13 Osypka Medical
10.13.1 Company Overview
10.13.2 Company Snapshot
10.13.3 Financial Overview
10.13.4 Product Listing
10.13.5 Entropy
10.14 Nihon Kohden Corporation
10.14.1 Company Overview
10.14.2 Company Snapshot
10.14.3 Financial Overview
10.14.4 Product Listing
10.14.5 Entropy
10.15 BPL Technologies
10.15.1 Company Overview
10.15.2 Company Snapshot
10.15.3 Financial Overview
10.15.4 Product Listing
10.15.5 Entropy
10.16 Schiller AG
10.16.1 Company Overview
10.16.2 Company Snapshot
10.16.3 Financial Overview
10.16.4 Product Listing
10.16.5 Entropy
10.17 Mindray
10.17.1 Company Overview
10.17.2 Company Snapshot
10.17.3 Financial Overview
10.17.4 Product Listing
10.17.5 Entropy
10.18 Dragerwerk AG & CO. KGaA
10.18.1 Company Overview
10.18.2 Company Snapshot
10.18.3 Financial Overview
10.18.4 Product Listing
10.18.5 Entropy
10.19 Lepu Medical Technologies
10.19.1 Company Overview
10.19.2 Company Snapshot
10.19.3 Financial Overview
10.19.4 Product Listing
10.19.5 Entropy
10.20 Fukuda Denshi Co., Ltd.
10.20.1 Company Overview
10.20.2 Company Snapshot
10.20.3 Financial Overview
10.20.4 Product Listing
10.20.5 Entropy
11. KOL Views
12. Project Approach
13. About the Publisher
14. Disclaimer
List of Tables
Table 1: Cardiac Monitoring Devices Market in Global (2023-2034)
Table 2: Cardiac Monitoring Devices Market in Global by Product Type (2023-2034)
Table 3: Cardiac Monitoring Devices Market in Global by End-Users (2023-2034)
Table 4: Cardiac Monitoring Devices Market in Global by Geography (2023-2034)
Table 5: Cardiac Monitoring Devices Market in North America (2023-2034)
Table 6: Cardiac Monitoring Devices Market in the United States (2023-2034)
Table 7: Cardiac Monitoring Devices Market in Canada (2023-2034)
Table 8: Cardiac Monitoring Devices Market in Mexico (2023-2034)
Table 9: Cardiac Monitoring Devices Market in Europe (2023-2034)
Table 10: Cardiac Monitoring Devices Market in France (2023-2034)
Table 11: Cardiac Monitoring Devices Market in Germany (2023-2034)
Table 12: Cardiac Monitoring Devices Market in United Kingdom (2023-2034)
Table 13: Cardiac Monitoring Devices Market in Italy (2023-2034)
Table 14: Cardiac Monitoring Devices Market in Spain (2023-2034)
Table 15: Cardiac Monitoring Devices Market in the Rest of Europe (2023-2034)
Table 16: Cardiac Monitoring Devices Market in Asia-Pacific (2023-2034)
Table 17: Cardiac Monitoring Devices Market in China (2023-2034)
Table 18: Cardiac Monitoring Devices Market in Japan (2023-2034)
Table 19: Cardiac Monitoring Devices Market in India (2023-2034)
Table 20: Cardiac Monitoring Devices Market in Australia (2023-2034)
Table 21: Cardiac Monitoring Devices Market in South Korea (2023-2034)
Table 22: Cardiac Monitoring Devices Market in Rest of Asia-Pacific (2023-2034)
Table 23: Cardiac Monitoring Devices Market in the Rest of the World (2023-2034)
Table 24: Cardiac Monitoring Devices Market in the Middle East (2023-2034)
Table 25: Cardiac Monitoring Devices Market in Africa (2023-2034)
Table 26: Cardiac Monitoring Devices Market in South America (2023-2034)
Table 27: Competitive Landscape
Table 28: Startup Funding & Investment Trends
List of Figures
Figure 1: Cardiac Monitoring Devices Market Drivers
Figure 2: Cardiac Monitoring Devices Market Restraints
Figure 3: Cardiac Monitoring Devices Market Opportunities
Figure 4: AI-Powered Innovations in Cardiac Monitoring Devices Market
Figure 5: US Tariff Impact on Cardiac Monitoring Devices Market
Figure 6: Regulatory Analysis (US, EU, Japan, China)
Figure 7: Porter's Five Forces Analysis
Figure 8: Competitive Analysis
Figure 9: Cardiac Monitoring Devices Market in Global (2023-2034)
Figure 10: Cardiac Monitoring Devices Market in Global by Product Type (2023-2034)
Figure 11: Cardiac Monitoring Devices Market in Global by End-Users (2023-2034)
Figure 12: Cardiac Monitoring Devices Market in Global by Geography (2023-2034)
Figure 13: Cardiac Monitoring Devices Market in North America (2023-2034)
Figure 14: Cardiac Monitoring Devices Market in the United States (2023-2034)
Figure 15: Cardiac Monitoring Devices Market in Canada (2023-2034)
Figure 16: Cardiac Monitoring Devices Market in Mexico (2023-2034)
Figure 17: Cardiac Monitoring Devices Market in Europe (2023-2034)
Figure 18: Cardiac Monitoring Devices Market in France (2023-2034)
Figure 19: Cardiac Monitoring Devices Market in Germany (2023-2034)
Figure 20: Cardiac Monitoring Devices Market in United Kingdom (2023-2034)
Figure 21: Cardiac Monitoring Devices Market in Italy (2023-2034)
Figure 22: Cardiac Monitoring Devices Market in Spain (2023-2034)
Figure 23: Cardiac Monitoring Devices Market in the Rest of Europe (2023-2034)
Figure 24: Cardiac Monitoring Devices Market in Asia-Pacific (2023-2034)
Figure 25: Cardiac Monitoring Devices Market in China (2023-2034)
Figure 26: Cardiac Monitoring Devices Market in Japan (2023-2034)
Figure 27: Cardiac Monitoring Devices Market in India (2023-2034)
Figure 28: Cardiac Monitoring Devices Market in Australia (2023-2034)
Figure 29: Cardiac Monitoring Devices Market in South Korea (2023-2034)
Figure 30: Cardiac Monitoring Devices Market in Rest of Asia-Pacific (2023-2034)
Figure 31: Cardiac Monitoring Devices Market in the Rest of the World (2023-2034)
Figure 32: Cardiac Monitoring Devices Market in the Middle East (2023-2034)
Figure 33: Cardiac Monitoring Devices Market in Africa (2023-2034)
Figure 34: Cardiac Monitoring Devices Market in South America (2023-2034)
Figure 35: Competitive Landscape
Figure 36: Startup Funding & Investment Trends
A selection of companies mentioned in this report includes, but is not limited to:

  • Boston Scientific Corporation
  • Neurosoft
  • ACSDiagnostics
  • Medtronic
  • Biotronik
  • Abbott
  • Koninklijke Philips NV
  • GE Healthcare
  • AliveCor Inc.
  • ZOLL Medical Corporation
  • Bexen Cardio
  • iRhythm Technologies, Inc
  • OSYPKA MEDICAL
  • Nihon Kohden Corporation
  • BPL Medical Technologies
  • Schiller AG
  • Mindray
  • Dragerwerk AG & Co. KGaA,
  • Lepu Medical Technologies
  • Fukuda Denshi Co., Ltd

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN16092026004107003653ID1111672620



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story